Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
<BR>
https://www.nejm.org/doi/full/10.1056/NEJMoa1711948
<BR>
Authors’ Conclusions: “Oral edoxaban was noninferior to subcutaneous dalteparin
Source: thesgem.com
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
https://www.nejm.org/doi/full/10.10
Authors’ Conclusions: “Oral edoxaban was noninferior to subcutaneous dalteparin with respect to the composite outcome of recurrent venous thromboembolism or major bleeding. The rate of recurrent venous thromboembolism was lower but the rate of major bleeding was higher with edoxaban than with dalteparin.”
SGEM: Our conclusion would have been “oral edoxaban had a higher rate of clinically relevant bleeding compared to dalteparin, was noninferior with respect to recurrent VTE and no statistically significant different was observed in all-cause mortality and event-free survival.”
- Visual Abstract by hellomynameisDrKirsty @KirstyChallen
#Edoxaban #Cancer #VenousThromboembolism #VTE #EBM #VisualAbstract #DVT #PE
Comments
More like this
The value of point-of-care ultrasound for detecting nail bed injury in [the] ED
<BR>
American Journal of Emergency Ruling out Pulmonary Embolism - ADJUST-PE, PE in Pregnancy, and the PERC rule
<BR>
- DenverEM
@DenverEMed
<BR>
#Pulmonary #Embolism #VisualAbstract Major Adverse Events and Relationship of NPO Status in Pediatric Sedation/Anesthesia Outside the Operating Room
<BR>
Source Paper: Point of Care Ultrasound for Appendicitis - Visual Abstract
<BR>
Can emergency physicians diagnose appendicitis with high specificity Practice Guidelines for Preoperative Fasting
<BR>
Infographic by Dr. Jesse Burk-Rafel
@jbrafel
<BR>
> 8 hours - Heavy foods (fried/fatty) and Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension